ATE439371T1 - Synthese von peptid t-1249 mit peptidzwischenproduktfragmenten - Google Patents

Synthese von peptid t-1249 mit peptidzwischenproduktfragmenten

Info

Publication number
ATE439371T1
ATE439371T1 AT05821840T AT05821840T ATE439371T1 AT E439371 T1 ATE439371 T1 AT E439371T1 AT 05821840 T AT05821840 T AT 05821840T AT 05821840 T AT05821840 T AT 05821840T AT E439371 T1 ATE439371 T1 AT E439371T1
Authority
AT
Austria
Prior art keywords
peptide
synthesis
intermediate fragments
peptide intermediates
fragments
Prior art date
Application number
AT05821840T
Other languages
German (de)
English (en)
Inventor
Yeun-Kwei Han
L Hodges
David Johnston
Hiralal Khatri
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE439371T1 publication Critical patent/ATE439371T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT05821840T 2004-12-30 2005-12-22 Synthese von peptid t-1249 mit peptidzwischenproduktfragmenten ATE439371T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64071604P 2004-12-30 2004-12-30
PCT/EP2005/013854 WO2006069729A1 (en) 2004-12-30 2005-12-22 Synthesis of peptide t-1249 using peptide intermediate fragments

Publications (1)

Publication Number Publication Date
ATE439371T1 true ATE439371T1 (de) 2009-08-15

Family

ID=36001047

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05821840T ATE439371T1 (de) 2004-12-30 2005-12-22 Synthese von peptid t-1249 mit peptidzwischenproduktfragmenten

Country Status (9)

Country Link
US (1) US7544665B2 (cg-RX-API-DMAC7.html)
EP (1) EP1856142B1 (cg-RX-API-DMAC7.html)
JP (1) JP4886703B2 (cg-RX-API-DMAC7.html)
CN (1) CN101133076B (cg-RX-API-DMAC7.html)
AT (1) ATE439371T1 (cg-RX-API-DMAC7.html)
CA (1) CA2593866C (cg-RX-API-DMAC7.html)
DE (1) DE602005016024D1 (cg-RX-API-DMAC7.html)
ES (1) ES2329270T3 (cg-RX-API-DMAC7.html)
WO (1) WO2006069729A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007007917A (es) * 2004-12-30 2007-08-14 Hoffmann La Roche Sintesis del peptido t-20 utilizando fragmentos peptidicos intermediarios.
CA2703113A1 (en) * 2007-10-27 2009-04-30 F. Hoffmann-La Roche Ag Insulinotropic peptide synthesis using solid and solution phase combination techniques
CA2707132A1 (en) * 2007-12-11 2009-06-18 F. Hoffmann-La Roche Ag Insulinotropic peptide synthesis using solid and solution phase combination techniques
DE102008017645A1 (de) 2008-04-04 2009-10-08 Carl Zeiss Smt Ag Vorrichtung zur mikrolithographischen Projektionsbelichtung sowie Vorrichtung zur Inspektion einer Oberfläche eines Substrats

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4010560B2 (ja) 1992-07-20 2007-11-21 ドューク ユニバーシティー Hiv複製を阻害する化合物
US6281335B1 (en) 1993-10-08 2001-08-28 Coulter Corporation Hybridoma and anti-KC-4 humanized monoclonal antibody
US6479055B1 (en) 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US5464933A (en) 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
US6469136B1 (en) * 1999-07-07 2002-10-22 Trimeris, Inc. Methods and composition for peptide synthesis
US20040209999A1 (en) * 2002-08-16 2004-10-21 Bohling James Charles Method of manufacturing polypeptides, including T-20 and T-1249, at commercial scale, and polypeptide compositions related thereto
AU2004200485A1 (en) * 2003-02-25 2004-09-09 Rohm And Haas Company Method of manufacturing T-20 and T-1249 peptides at commercial scale, and T-20 and T-1249 compositions related thereto
MX2007007917A (es) 2004-12-30 2007-08-14 Hoffmann La Roche Sintesis del peptido t-20 utilizando fragmentos peptidicos intermediarios.

Also Published As

Publication number Publication date
US7544665B2 (en) 2009-06-09
JP2008526699A (ja) 2008-07-24
CA2593866C (en) 2013-08-06
CN101133076A (zh) 2008-02-27
ES2329270T3 (es) 2009-11-24
CA2593866A1 (en) 2006-07-06
CN101133076B (zh) 2011-07-13
US20060173163A1 (en) 2006-08-03
DE602005016024D1 (de) 2009-09-24
EP1856142A1 (en) 2007-11-21
WO2006069729A1 (en) 2006-07-06
JP4886703B2 (ja) 2012-02-29
EP1856142B1 (en) 2009-08-12

Similar Documents

Publication Publication Date Title
UA97516C2 (ru) Полностью человеческое моноклональное антитело против vap-1
DE602005008996D1 (de) Radiofluorierte peptide
WO2006131564A3 (de) Neue cystein-verarmte hydrophobinfusionsproteine, deren herstellung und verwendung
ATE507235T1 (de) Synthese von glucagon-ähnlichen peptiden
RU2012111708A (ru) Гуманизированные антитела к cdcp1
TN2009000194A1 (en) Novel antiproliferation antibodies
DK1511761T3 (da) Fremgangsmåde til fremstilling af cykliske peptider
IL184080A (en) Synthesis of peptide t-20 using peptide intermediate fragments
WO2008113970A3 (en) Peptides
IL184081A0 (en) Synthesis using peptide intermediate fragments iii
PL1879612T3 (pl) Zastosowanie peptydów natywnych i ich zoptymalizowanych pochodnych do szczepienia
ATE439371T1 (de) Synthese von peptid t-1249 mit peptidzwischenproduktfragmenten
WO2008113770A3 (en) Anti-androgen peptides and uses thereof in cancer therapy
WO2009011259A1 (ja) 新規dna断片およびそれを含む組換えベクター、それらによって形質転換された形質転換体、ならびにそれらの利用
MX2007013400A (es) Metodo de sintesis de peptidos.
MX2010003179A (es) Metodos de sintesis para peptidos anti-vih terapeuticos.
WO2004081033A3 (en) Synthesis of proteins by cell-free protein expression
WO2007078633A3 (en) Bacteriocin inducer peptides
ATE512159T1 (de) Cyclodipeptidsynthetasen und ihre verwendung zur synthese von cyclo(leu-leu)cyclodipeptid
WO2005072766A3 (en) Peptides that bind to hsp90 proteins
WO2020120198A8 (en) Linear solution phase routes for wnt hexapeptides
DE602005003922D1 (de) Synthese von spongosin
WO2011068538A3 (en) General method for generating ultra-high affinity binding proteins
WO2008029138A3 (en) Peptides and methods
AU2003264736A1 (en) Fiber-shaping peptides capable of interacting with self-assembling peptides

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties